Végvári Ákos
Clinical Protein Science & Imaging, Department of Biomedical Engineering, Lund University, Sweden.
CREATE Health, Lund University, Sweden; Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX, USA.
Biomark Med. 2015;9(9):869-76. doi: 10.2217/bmm.15.64. Epub 2015 Sep 2.
Advances in development of mass spectrometry (MS) are successfully utilized for spatial localization of pharmaceutical compounds in these tissue sections. Today MS instruments can be used in imaging mode when the datasets are generated from the surface of the tissue over an array of acquisition positions. This review is focused on the technological developments of matrix-assisted laser desorption/ionization MS imaging (MALDI-MSI) and related sample preparation procedures. MALDI-MSI provides a sensitive and label-free approach for imaging of drugs and their metabolites. Due to these features, MALDI-MSI is expected to become a standard technique in pharmaceutical development providing complementary information to current methods.
质谱(MS)技术的发展成果已成功应用于这些组织切片中药物化合物的空间定位。如今,当在一系列采集位置上从组织表面生成数据集时,MS仪器可用于成像模式。本综述聚焦于基质辅助激光解吸/电离质谱成像(MALDI-MSI)的技术发展及相关样品制备程序。MALDI-MSI为药物及其代谢物的成像提供了一种灵敏且无需标记的方法。基于这些特性,MALDI-MSI有望成为药物研发中的一项标准技术,为现有方法提供补充信息。